Progressive cardiac remodeling, including the myopathic process in the adjacent zone following myocardial infarction (MI), contributes greatly to the development of cardiac failure. Cardiomyoplasty using bone marrow-derived mesenchymal stem cells (MSCs) has been demonstrated to protect cardiomyocytes and/or repair damaged myocardium, leading to improved cardiac performance, but the therapeutic effects on cardiac remodeling are still under investigation. Here, we tested the hypothesis that MSCs could improve the pathological remodeling of the adjacent myocardium abutting the infarct. Allogeneic ovine MSCs were transplanted into the adjacent zone by intracardiac injection 4 hours after infarction. Results showed that remodeling and contractile strain alteration were reduced in the adjacent zone of the MSC-treated group. Cardiomyocyte hypertrophy was significantly attenuated with the normalization of the hypertrophy-related signaling proteins phosphatidylinositol 3-kinase ␣ (PI3K␣), PI3K␥, extracellular signal-regulated kinase (ERK), and phosphorylated ERK (p-ERK) in the adjacent zone of the MSC-treated group versus the MI-alone group. Moreover, the imbalance of the calcium-handling proteins sarcoplasmic reticulum Ca 2؉ adenosine triphosphatase (SERCA2a), phospholamban (PLB), and sodium/calcium exchanger type 1 (NCX-1) induced by MI was prevented by MSC transplantation, and more strikingly, the activity of SERCA2a and uptake of calcium were improved. In addition, the upregulation of the proapoptotic protein Bcl-xL/Bcl-2-associated death promoter (BAD) was normalized, as was phospho-Akt expression; there was less fibrosis, as revealed by staining for collagen; and the apoptosis of cardiomyocytes was significantly inhibited in the adjacent zone by MSC transplantation. Collectively, these data demonstrate that MSC implantation improved the remodeling in the region adjacent to the infarct after cardiac infarction in the ovine infarction model. STEM CELLS TRANSLATIONAL MEDICINE 2012;1: 000 -000 
INTRODUCTION
Interventional therapy to address the damage to the myocardium caused by myocardial infarction (MI) and cardiomyocyte death, inflammation, alterations of collagen matrix, microvascular rarefaction, structural and molecular remodeling, and the resultant functional impairment is a major challenge in cardiovascular medicine [1, 2] . Stem cell therapy is under study as a treatment option and potentially provides the necessary signals and factors for cellular repair to protect the damaged myocardium, and cellular repair to restore or regenerate the injured myocardium [3] . Among the varieties of stem cells described, bone marrow-derived mesenchymal stem cells (MSCs) are a leading therapeutic candidate because of their relative ease of isolation, stable phenotype, and limited rejection [4, 5] . Several aspects of heart tissue regeneration, including increased blood vessel density, sparing of at-risk myocardium, and even new cardiomyocytes from MSC stimulation of cardiac stem cells, have been reported [6 -10] . Accumulating evidence also suggests that MSCs provide benefits beyond their cell replacement potential by providing growth factors and cytokines and limiting inflammation [6] . The potential of MSC transplantation for the treatment of MI has been investigated in different animal models as well as in patients, and significant improvement of overall cardiac performance or local cardiac function has been reported [11] [12] [13] . In recent years, studies of the effects of MSC transplantation on structural and molecular tissue remodeling, which is a determinant of the clinical course of cardiac failure, have become more prominent. Several groups have documented the reduced ventricular cavity dilation, the prevention of infarct expansion, and the mitigation of fibrosis after MSC transplantation [14 -17] . However, the effects of MSC transplantation on the remodeling of surviving myocardium remain to be investigated.
The adjacent, nonischemic myocardium abutting the infarct is at potential peril of chronic stress following MI. Because of its unique juxtaposition between the noncontractile infarct scar and the viable contractile myocardium, the adjacent myocardium is imposed with highly abnormal stress patterns. The altered stress not only decreases strain in the adjacent region in the direction of the infarct but also transfers strain into the areas of myocardium that lack the contractile elements necessary to generate compensatory strain; these areas thus undergo remodeling, including strain alteration, myocyte hypertrophy, and imbalance of calcium-handling protein with increased apoptosis soon after MI [18 -22] . This myopathic process in normally perfused myocardium appears to be localized initially to the myocardium abutting the infarct, but it later extends during the remodeling process to continuous segments, making these hypocontractile as well [23] . The remodeling in this adjacent area has been proposed as the main mechanism of the nonischemic infarct extension following MI, which plays an important role in promoting progressive cardiac remodeling and eventually cardiac failure [24, 25] . Therefore, the regional, nonischemic remodeling plays a key role in the development of progressive cardiac remodeling and eventually cardiac failure. However, thus far, little is known about the impact of MSCs on cellular and molecular remodeling in this region. We therefore used an ovine model of 25% chronic myocardial infarction by permanent ligation of the left anterior descending coronary artery and associated vessels to evaluate the impact of early intervention with local intracardiac injection of MSCs in the adjacent zone after cardiac infarction, and we examined the regional remodeling at the tissue, cellular, and molecular levels. Our results provide an important view into associated changes in the tissue abutting the infarct following MSC transplantation that may account for much of the improvement to adverse remodeling after myocardial infarction.
MATERIALS AND METHODS

Isolation and Culture of Ovine MSCs
Fresh bone marrow aspirates for preparation of allogeneic MSCs were obtained from the iliac crest of adult sheep (approximately 1-4 years old) under general anesthesia according to procedures approved by the animal care and use committee of the University of Maryland School of Medicine. After dilution with the same volume of 0.9% saline solution, the bone marrow aspirates were layered on Ficoll-Paque Premium (1.077 g/ml; GE Healthcare, Uppsala, Sweden, http://www.gehealthcare.com) and centrifuged for 40 minutes at 1,600 rpm at room temperature. The visible middle layer containing enriched bone marrow mononuclear cells (MNCs) was collected and washed with three volumes of phosphate-buffered saline (PBS), and the cells were centrifuged to remove any remaining Ficoll solution. Isolated bone marrow MNCs were resuspended and plated in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Carlsbad, CA, http:// www.invitrogen.com) with low glucose supplemented with penicillin (100 IU/ml)/streptomycin (100 g/ml) and 10% (vol/vol) MSC fetal bovine serum (FBS) (Gibco), incubated at 37°C in the presence of 5% CO 2 . After 24 hours, the nonadherent cells were removed, and fresh complete medium was added. Medium was changed every 2 days by changing half of the volume with fresh complete medium. MSCs were subcultured using TrypLE Express (Gibco) when at 70%-80% confluence.
Flow Cytometric Analysis
Flow cytometric analysis was used to characterize the cell surface antigen expression of ovine MSCs using markers positively and negatively associated with MSCs. Cells were incubated with a primary antibody mouse anti-sheep CD44 (AbD Serotec, Raleigh, NC, http://www.ab-direct.com), mouse anti-human CD166 (BD Biosciences, San Diego, CA, http://www. bdbiosciences.com), mouse anti-human CD34 (BD Biosciences), mouse anti-sheep CD45 (AbD Serotec), mouse antihuman CD105 (BD Biosciences), mouse anti-human CD106 (BD Biosciences), or isotype-matched control (AbD Serotec) for 20 minutes at room temperature. After being washed to remove unbound primary antibody, cells were incubated for 20 minutes in a 1:100 dilution of Alexa Fluor 488-conjugated goat antimouse IgG on ice. Flow cytometric analysis was performed using a FACSCalibur analyzer (Becton, Dickinson and Company, Bohemia, NY, http://www.bd.com). Typically, for each sample 5,000 events were analyzed on the flow cytometer and stored as list mode data for further analysis using WinMDI software (Windows Multiple Document Interface Flow Cytometry Application; Joseph Trotter). Positive fluorescence was defined as the level of fluorescence greater than 99% of the corresponding isotypematched control antibody.
Osteogenic, Chondrogenic, and Adipogenic Differentiation
To cause differentiation of MSCs toward osteoblasts, chondrocytes, and adipocytes, cells at passage 4 were seeded onto 12-well plates at 1 ϫ 10 4 cells per cm 2 for adipogenesis and 5 ϫ 10 3 cells per cm 2 for osteogenesis or at the center of multiwell plate wells with 5-l droplets of cell solution of 1.6 ϫ 10 7 for chondrogenesis in DMEM supplemented with penicillin (100 IU/ml)/ streptomycin (100 g/ml) and 10% (vol/vol) MSC FBS (Gibco), incubated at 37°C in the presence of 5% CO 2 . Two days later, culture medium was replaced with differentiation medium (Gibco), and it was changed every 2 days thereafter. At 14 days for adipogenesis and 28 days for osteogenesis and chondrogenesis, samples were fixed with 4% paraformaldehyde for 30 minutes. Histological staining was performed using Oil Red O for adipocytes, Alcian blue for chondrocytes, and alizarin red for osteoblasts.
MI Protocol and Sonomicrometry Array Localization
An MI was surgically induced in 10 male sheep (5 MI only, 5 MIϩMSC) using our published method [21] . In addition, four sheep were used as the sham group. For the sham group, sheep underwent the same surgical procedure without MI and MSC treatment. Briefly, adult sheep weighing 40 -60 kg were anesthetized and instrumented. Polypropylene snares were placed around the left anterior descending and second diagonal coronary arteries and momentarily tightened (Ͻ30 seconds) to demarcate the border of the future infarct. Four specific transducers (2 mm; Sonometrics Corporation, London, ON, Canada, http://www.sonometrics.com) were placed at the superior, inferior, medial, and lateral aspects of the transiently ischemic myocardium, and an additional transducer was placed in the center of this ischemic region. An additional 11 transducers were sutured into the mid-myocardium of the left ventricular (LV) free wall to create a final array of three short-axis aligned rows of five transducers with an additional transducer in the apex. The wires of the transducers were secured together with silk ties and tunneled subcutaneously, and their respective skin buttons were exposed to allow for future data acquisition. An anteroapical infarction was produced by ligating the left anterior descending artery and its diagonal branches, resulting in an infarction of approximately 25% of the LV mass. This technique has been shown to reproducibly create MI of consistent size. All animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Research Council, Washington, DC, 1996). The sheep were randomized to receive either nothing or a specific concentration of MSCs. For the purposes of control values for the subsequent myocardial biochemical analysis, LV myocardial samples were collected from the sham sheep. Areal strain () between any pair of triangular crystals at two specific time frames can be calculated as follows:
where S ED and S ES indicate the triangular area at end diastolic (ED) and end systolic (ES) instants, and S EDpreMI is the triangular area at ED instant pre-MI. con and rem are the contractile strain and remodeling strains, respectively. The contractile strain, defined as LV deformation during an individual cardiac cycle, was used to assess regional myocardial contractility. The remodeling strain was defined as LV deformation over time and was calculated by comparing the end-diastole geometries at one data collection time point relative to the pre-MI measurement.
Preparation of MSCs for Injection
Allogeneic MSCs at passages 4 -5 were harvested with TrypLE Express (Gibco) and resuspended in PBS. Four hours post-MI, a total of 2 ϫ 10 8 cells in 0.3 ml were delivered by direct injection into the clearly identifiable border zone region adjacent to the infarct on the wall of the LV. A total of six injections were performed in each animal, with each injection containing ϳ3.33 ϫ 10 7 cells.
Histological Staining and Detection of Apoptosis by Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling
Tissue samples of the remote and adjacent regions harvested at 12 weeks after MI were fixed, embedded in paraffin, and cut into 5-m-thick sections. The sections were stained with hematoxylin and eosin, examined under a microscope (Axioskop; Carl Zeiss, Jena, Germany, http://www.zeiss.com), and digitally imaged. Cardiomyocyte size was calculated from the recorded digital images by using ImageJ software (NIH). For the detection of apoptosis, tissue sections were deparaffinized and permeabilized with proteinase K (25 g/ml in 100 mM Tris HCl). An in situ apoptotic cell death detection kit (TMR red; Roche Applied Science, Indianapolis, IN, https://www.roche-applied-science.com) based on the terminal deoxynucleotidyl transferase dUTP nickend labeling (TUNEL) assay was used per the manufacturer's instructions to detect apoptotic cells. Sections were mounted with antifade Vectashield mounting medium containing 4Ј,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA, http://www.vectorlabs.com) to stain DNA in the nuclei. Sections were examined with a Zeiss Axiovert 200 microscope and a Zeiss LSM 510 META laser scanning confocal microscope. Quantitative analysis of apoptotic nuclei was performed on two or three heart sections from four or five different hearts. The percentage of apoptotic nuclei per section was calculated by counting the total number of TUNEL staining nuclei divided by the total number of DAPI-positive nuclei in 10 randomly selected fields at a magnification of ϫ20.
For picrosirius red staining, 5-m paraffin sections were deparaffinized with standard xylene/ethanol series and rinsed with distilled water. The sections were immersed in 0.2% phosphomolybdic acid for 1 minute followed by staining in 0.1% Sirius red in saturated picric acid for 90 minutes. The slides were then washed with 0.01 N HCl for 2 minutes, rinsed with 70% ethanol followed by 100% ethanol and then xylene, and mounted using Permount (Fisher Scientific, Pittsburgh, PA, http://www.fishersci.com). The sections were examined under the Zeiss Axiovert 200 microscope (Carl Zeiss USA, Thornwood, NY, http://www.zeiss.com/microscopy).
Determination of SERCA2a Activity and 45
Ca Uptake
The ATPase assay and thapsigargin (Tg)-sensitive 45 Ca uptake were performed based on the method of Kyte [26] and Xu et al. [27] with some modifications. Briefly, cardiac muscle sarcoplasmic reticulum (SR) vesicles were isolated according to the method developed by Chu et al. [28] with modifications similar to those described previously [29] . Calcium-45 ( 45 Ca) at a concentration of 37.92 mCi/ml was from PerkinElmer Life and Analytical Sciences (Boston, MA, http://www.perkinelmer.com). Tg, a specific inhibitor of cardiac sarcoplasmic reticulum Ca 2ϩ adenosine triphosphatase (SERCA2a), was from LC Laboratories (Woburn, MA, http://www.lclabs.com). The enzymatic activity was defined as the Tg-sensitive hydrolysis of ATP in the presence of Ca 2ϩ (10 M). The incubation mixture contained 15 mM imidazole/HCl, pH 7.4, 3 mM ATP, and 5 mM Mg 2ϩ in a final volume of 0.5 ml and was brought to and maintained at 37°C in a water bath. The reaction was initiated by adding SR vesicles and stopped after 30 minutes. The color was allowed to develop for 30 minutes at room temperature, and the phosphate generated in the reaction was then determined spectrophotometrically at 700 nm. For the measurement of 45 Ca uptake, in addition to cardiac (0.15 mg/ml) SR vesicles, the reaction mixture contained Ca 2ϩ (10 mM), 45 Ca (1 mCi/ml), Mg 2ϩ (5 mM), and ATP (3 mM). Samples were incubated in the presence and absence of Tg at 37°C for 20 minutes. The reaction was terminated by centrifuging the sample at 14,000 rpm for 15 minutes, and the pellet was washed three times with 15 mM imidazole/HCl buffer, pH 7.2, and then dissolved in 100 ml of 10% SDS solution. The radioactivity was determined by a ␤-scintillation counter. Any 45 Ca transport in the presence of Tg was considered to represent nonspecific 45 Ca uptake.
Western Blot Analysis
Immunoblotting was performed as described previously [21, 22] . In brief, tissue samples corresponding to different regions were collected, rapidly frozen in liquid nitrogen, and stored at Ϫ80°C. 
Statistical Analysis
All data are presented as mean Ϯ SEM. One-way repeated measures analysis of variance (ANOVA) was used to compare differences among groups. All ANOVAs were followed by multiple comparisons with the least significant difference correction. The significance level (p) was set at .05.
RESULTS
Characterization of MSCs
MSCs isolated by Ficoll gradient centrifuge and expanded as described above were characterized by flow cytometry, microscopy, and differentiation assay. The MSCs uniformly displayed a high level of expression of the hyaluronan receptor CD44 and CD166 and lacked expression of the leukocyte marker CD45 and the endothelial marker CD34 (Fig. 1A) . Furthermore, the majority of antibodies reactive with human MSCs did not exhibit any reactivity with ovine MSCs, including CD106 and CD105 (Fig. 1A) . Morphological observation showed that the MSCs exhibited spindle-shaped, fibroblastic morphology in culture (Fig. 1B) . At passage 4, the MSCs readily differentiated into Oil Red O-positive adipocytes (Fig. 1C) , alizarin red-positive mineralizing cells (osteocytes) (Fig. 1D) or Alcian blue-positive chondrocytes (Fig. 1E ) when incubated in the respective differentiation media for 14 days of adipogenesis or 28 days of osteogenesis and chondrogenesis.
Reduction of Cardiac Strain Alteration by MSC Transplantation
Regional contractile and remodeling strains in the adjacent and remote zones of the MI and the MSC-treated groups were evaluated using sonomicrometry transducers implanted on the surface of the heart ( Fig. 2A) . MI induced the reduction in contractile function (from Ϫ15% to Ϫ10%) immediately after infarction in both the adjacent zone and remote zone (Fig. 2C) . The contractility gradually recovered to the level of preinfarction in the remote zone of both the MI group and the MSC-treated group (Fig.  2C) . However, the recovery of the contractility was observed in the adjacent zone of the MSC-treated group and almost reached the level of preinfarction by 4 weeks, whereas the contractility in the adjacent zone of the MI group remained depressed (Fig.  2D ).
Cardiac Hypertrophy Was Attenuated by MSC Implantation
To investigate the effects of MSC transplantation on hypertrophy, the cardiomyocyte size and the expression of hypertrophyrelated signaling proteins were assessed in the adjacent and remote zones of the sham, MI, and MSC-treated groups. Examination of the cardiomyocyte cross-sectional area confirmed that the cardiomyocytes in the MSC-treated group had a basal hypertrophy, a little larger than but not significantly different from sham group in the adjacent zone, whereas the ones in the MI group developed marked hypertrophy (3,888.00 Ϯ 653.37 vs. 2,533.00 Ϯ 144.37; MI vs. sham, p Ͻ .05) in the adjacent zone by 12 weeks (Fig. 3A, 3B ). There was a small increase in cardiomyocyte size in the remote zones of both the MI and the MSC-treated hearts compared with the sham group, but there was no significant difference among these three groups (Fig. 3A,  3B ). Figure 3C shows representative photographs of picrosirius red staining of heart sections of the sham, MI, and MSC-treated groups for collagen deposition after 12 weeks. Less collagen staining was found in the adjacent regions of animals that received MSCs. (Fig. 4A-4E) . No significantly altered expression of PI3K␣, PI3K␥, and p-ERK/ERK was observed in the remote zone of sham, MI, and MSC-treated groups (Fig. 4A-4E ).
MSC Implantation Normalized the Expression of Calcium-Handling Proteins
The calcium-handling proteins SERCA2a, PLB, and NCX-1 were assayed for expression level in the sham, MI-only, and MSCtreated groups by Western blot. (Fig. 5A-5E ). However, the imbalanced expression was completely normalized by MSC MSCs Mitigate Regional Heart Remodeling transplantation (Fig. 5A-5E ). There were no differences in expression of SERCA2a, PLB, and NCX-1 in the remote zones of the sham, MI, and MSC-treated groups (Fig. 5A-5E ). More strikingly, the Ca 2ϩ ATPase (SERCA2a) activity (53 Ϯ 4% vs. 184 Ϯ 55%, MI vs. MSC-treated) and the 45 Ca 2ϩ uptake (48 Ϯ 13% vs. 191 Ϯ 27%, MI vs. MSC-treated) were significantly improved by MSC transplantation in the adjacent zone (Fig. 5F, 5G) . No significant changes in Ca 2ϩ ATPase activity or 45 Ca 2ϩ uptake were observed in the remote zones of the sham, MI, and MSC-treated groups (Fig. 5F,  5G ).
MSC Transplantation Inhibited Cardiac Apoptosis
To examine whether MSC transplantation inhibits the apoptosis of the regional myocardium in the adjacent zone, proteins of proapoptosis and apoptotic cardiomyocytes in the sham, MI, and MSC-treated groups were assayed by Western blotting and TUNEL staining, respectively. Significantly increased expression of Bcl-xL/Bcl-2-associated death promoter (BAD) (0.82 Ϯ 0.11 vs. 0.54 Ϯ 0.03; MI vs. sham, p Ͻ .05) in the adjacent zone of the MI group has been observed compared with the sham group (Fig.  6A, 6B) . However, the upregulation was completely normalized in the adjacent zone of the MSC-treated group (Fig. 6A, 6B) . No significant change in the expression of BAD was observed in the remote zone of the sham, MI, and MSC-treated groups (Fig. 6A,  6B ). TUNEL staining also showed that significant increase of apoptotic cells induced by MI in the adjacent zone was inhibited by MSC transplantation (5.9 Ϯ 0.3 vs. 0.6 Ϯ 0.1; MI vs. sham, p Ͻ .05). There was no difference in apoptotic cells in the remote zone of the sham, MI, and MSC-treated groups (Fig. 6C, 6D) . We also examined the expression of Akt and phospho-Akt in the sham and infarcted animals, and this demonstrated a continued elevated expression of phospho-Akt in the MI animals that was not seen in the MI animals treated with MSC injection (Fig. 6E,  6F ). 
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Alteration of cardiac strain is the reflection of the myocardium resulting from cardiac remodeling. Several aspects of cardiac remodeling, including infarct expansion, fibrosis, and cavity dilation, contribute to the alteration. Alteration of cardiac remodeling strain impairs cardiac function, resulting in further remodeling [19, 20] . Our group has previously demonstrated that the regional remodeling strain is closely associated with the expression of proapoptotic and calcium-handling proteins, such as BAD and SERCA2a, in the adjacent zone [21, 22, 23] , indicating the induction of cardiac strain alteration on cardiac apoptosis and hypertrophy. Our current results demonstrate that the remodeling strain alteration in the adjacent zone was improved by MSC transplantation (Fig. 2D) . Furthermore, the contractile strain, which reflects cardiac function, was also improved (Fig. 2B) .
A hallmark response of cardiomyocytes to stress is the development of hypertrophy. Generally, cardiomyocyte hypertrophy is believed to have a compensatory function by diminishing wall stress following MI. Conversely, sustained cardiac hypertrophy represents one of the most common causes of cardiac failure [30] . In fact, studies have shown that pathological hypertrophy induced by MI is accompanied by the alteration of apoptosis regulators, resulting in increased sensitivity to apoptosis induction [31] . Our results demonstrated that cardiomyocyte hypertrophy could be significantly attenuated by MSC transplantation in the adjacent zone in large animals. Moreover, our study further demonstrated that the elevated activity of hypertrophyrelated signal as evidenced by the increased expression of PI3K␣, PI3K␥, and p-ERK (Fig. 4A-4E ), which may lead to cardiomyocyte hypertrophy, was normalized in the adjacent zone by MSC transplantation. These results showed that MSCs could prevent regional hypertrophy induced by MI.
To date, no other study has examined the effects of MSC transplantation on the expression of the main calcium-handling proteins, SERCA2a, PLB, and NCX-1. Contractility and relaxation are mainly dependent upon the rise and fall of cytosolic Ca 2ϩ , closely linked to the expression/function of these Ca 2ϩ -regulatory proteins. Reduced function of the sarcoplasmic reticulum and accumulation of free calcium may reflect a major defect in excitation contraction coupling in human heart failure [32, 33] . Proper function of the SERCA2a pump by PLB is necessary to maintain dynamic regulation of cardiac contractility in normal conditions and during pathophysiological states [34] . The changes in intracellular calcium handling, concomitant with structural remodeling over time, could have a crucial role in progression and the hypertrophic response toward heart failure. Our results showed that the imbalance of calcium-handling proteins induced by MI was normalized by MSC delivery as evidenced by the normalization of SERCA2a, PLB, and NCX-1 in the adjacent zone. More strikingly, the activity of SERCA2a and uptake of calcium into sarcoplasmic reticulum was significantly improved by MSC transplantation, indicative of the possible mechanism of functional improvement. This may be one of the reasons that MSC transplantation can improve cardiac function after infarction.
Inhibition of cardiac apoptosis in the adjacent zone by MSC transplantation was also demonstrated at 12 weeks (Fig. 6) . Cardiomyocyte apoptosis has been shown to be a key factor in the development and progression of post-MI remodeling that can lead to chronic heart failure [34] . Furthermore, we demonstrated that the activation of BAD was normalized in the adjacent zone by MSC transplantation. The ratio of phospho-Akt to total Akt was elevated in the adjacent zone of the MI animals. This elevated expression of phosho-Akt was not seen in the MI animals treated with MSC injection (Fig. 6E, 6F ). It is possible that there was an earlier phosho-Akt elevation in the MSC-treated animals that was returned to normal by the time of sacrifice.
Our current studies, together with previous work performed in the pig model [10] , provide direct measurable evidence of MSC inhibition of cardiomyocyte apoptosis in large animal models following infarction. These effects may be more important than the actual replacement of injured cardiomyocytes by the implanted MSCs, which were not provided in large enough numbers to replace the damaged cells. Most investigators report that less than 1% of cells can be identified by 4 days after injection and that there is an absence of cells by 3 weeks [35] [36] [37] . In spite of their initial intuition, investigators have shown that direct transdifferentiation of MSCs into cardiomyocytes or fusion with cardiomyocytes to replace or repair heart muscle, respectively, seems to be a quantitatively insignificant part of the limited process of repair. It appears that MSCs alter the tissue microenvironment by elaboration of soluble factors that encourage angiogenesis, survival, and immune regulation, which limits inflammation. Expression of these and other yet unidentified factors may explain MSCs' capacity to promote survival and proliferation of endogenous cells [38 -40] , including angiogenesis, inhibition of inflammation, and apoptosis. Many of these regulatory proteins are expressed by a specific subpopulation of cells. Thus, it is likely that the functional complexity of the broad family of MSCs explains their expanded potential for therapeutic efficacy. Consistent with the paracrine theory of MSC repair, our results have indicated that injection of MSCs into the border zone of the infarct reduced the regional endothelial cell abnormalities and inhibited myocardial apoptosis.
CONCLUSION
Our study demonstrated that the maladaptive cardiac remodeling in the region adjacent to the infarct could be significantly improved by MSC transplantation, as evidenced by normalization of cardiomyocyte hypertrophy, cardiac apoptosis, calciumhandling protein expression/activity, and cardiac strain. These findings support the therapeutic effects of MSC transplantation on cardiac remodeling after myocardial infarction. 
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